National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Benepali® is a biosimilar of the TNF-α inhibitor Etanercept (Enbrel®) for the treatment of patients with rheumatoid arthritis, psoriatic arthritis, axial spondylitis and plaque psoriasis.

 

Rapid Review

Commenced Completed Outcome
22/03/2016 10/05/2016 Full Pharmacoeconomic Evaluation not Recommended